2 results match your criteria: "University Multiprofile Hospital for Active Treatment "Saint Ivan Rilski"[Affiliation]"
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
Lancet Infect Dis
December 2024
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Article Synopsis
- The text discusses the impact of pneumococcal conjugate vaccines (PCVs), specifically PCV10 and PCV13, on invasive pneumococcal disease (IPD) globally, highlighting how these vaccines have reduced the prevalence of disease caused by vaccine-type serotypes after extensive use.
- It describes the methodology of data collection from various surveillance sites, which aimed to evaluate IPD cases that occurred five years after the vaccines were implemented, focusing on different age groups for analysis.
- Findings indicate significant differences in serotype distribution between PCV10 and PCV13 sites; notably, certain serotypes, such as 19A and serotype 3, were prevalent in specific age groups, signaling ongoing challenges in controlling
Neuropsychological and psychological dysfunctions associated with coronavirus disease 2019: a case report.
J Med Case Rep
October 2021
Neurosurgery Clinic, University Multiprofile Hospital for Active Treatment "Saint Ivan Rilski", 15 Akademik Ivan Geshov Blvd., Sofia, Bulgaria.
Background: Patient's account of personal experiences of having lived through coronavirus disease 2019 is important for understanding the magnitude of the debilitating impact of the infection. There is increasing recognition that the infection impedes multiple functional domains, but to date the evidence remains scarce. Moreover, to the author's knowledge, there are no documented cases reporting on research data derived from self-reflective first-person experience.
View Article and Find Full Text PDF